Arrowhead Pharma (ARWR) PT Raised to $32 at Bernstein
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $86.59 -0.06%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Bernstein analyst William Pickering raised the price target on Arrowhead Pharma (NASDAQ: ARWR) to $32.00 (from $27.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Broadridge Financial (BR) PT Raised to $180 at UBS, Neutral Rating Maintained
- MGM Resorts (MGM) PT Raised to $55 at Argus
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
